Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)
Condition(s) studied
Study summary
The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)
Eligibility
Primary outcome measure(s)
- Graft patency after CABG — 12-36 months
Defined as patency on CCTA (FitzGibbon A) without previous graft failure identified on CCTA and/or invasive coronary angio (ICA) since CABG, intention to treat (ITT) analysis.
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Heart Disease, Haukeland University Hospital | Bergen | Norway | Enrolling By Invitation |
| St Olavs University Hospital | Trondheim | Norway | Not Yet Recruiting |
| Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine | Gothenburg | Sweden | Enrolling By Invitation |
| Dep of Vascular and Thoracic Surgery | Örebro | Sweden | Active Not Recruiting |
| Department of Cardiothoracic Surgery Karolinska University Hospital | Stockholm | Sweden | Enrolling By Invitation |
| University Hospital Linköping | Linköping | Östergötland County | Recruiting |
More University Hospital, Linkoeping trials in Sweden
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04783701 on ClinicalTrials.gov ↗ ← All trials in Sweden